Callum Osmand’s breakout season has been halted by a significant hamstring injury, and Celtic are now preparing to be without the young striker for an extended period.
The 20-year-old, who had rapidly become one of the most discussed young players in recent years, was forced off during the Europa League defeat to Midtjylland a month ago. Subsequent assessments revealed the need for surgery, a setback that has kept him sidelined ever since.
While Celtic have yet to confirm a specific timeframe for his return, the expectation inside the club is that Osmand will be absent for a number of months, with his comeback projected towards the latter stages of the season.
Given the nature of hamstring operations, recovery tends to be cautious rather than accelerated, especially for a player whose game is built on explosive movement.
Despite the seriousness of the injury, there was a welcome dose of optimism in recent. Vidarecovery, the Glasgow clinic specialising in medical-grade pressure oxygen therapy, shared an update on Osmand’s rehabilitation progress.
Their treatment facility, the only one in the city offering this level of oxygen-based recovery technology, confirmed that the striker has now reached the stage where he can fully participate in their programme following his post-surgery stabilisation phase.
For Celtic supporters, it is the first meaningful update since the immediate aftermath of the surgery, and one that suggests Osmand’s recovery is moving in the right direction, with the youngster now able to walk confidently for the first time since the operation.
Osmand entering this stage of treatment is significant. Medical-grade hyperbaric oxygen therapy (HBOT) is used widely in elite sport, from the Premier League to the NBA, to speed healing and improve tissue recovery after soft-tissue surgery.
Celtic players in previous years have used similar facilities abroad, but having such technology available locally gives Osmand a stable, consistent rehabilitation environment close to Lennoxtown.
The club’s medical staff are understood to be in regular communication with Vidarecovery, ensuring a unified approach to the player’s progression.
For Osmand, whose rise from academy hopeful to first-team contributor has been swift, this period is as much psychological as physical.
The timing is undeniably frustrating, both for the player and for Wilfried Nancy, who would have welcomed Osmand’s energy and directness as Celtic transition into a new tactical model.
The teenager had shown flashes of real potential early in the campaign, contributing goals in domestic competition and impressing with his pressing intensity. Losing him for months forces Celtic to rely heavily on Daizen Maeda, Johnny Kenny and other rotational forwards at a time when squad depth is already being tested.
Even so, the long-term view remains positive.
A late-season return, whether in March, April or early May, depending on how his hamstring responds, would give Celtic an additional attacking option just as the title race tightens and the squad enters its most demanding stretch. Considering his youth, Celtic will prioritise ensuring the injury does not become a recurring issue, one that could disrupt his development over several seasons.
What stands out most from Vidarecovery’s update is confidence, not urgency. Celtic will not be rushing Osmand back into training simply to meet short-term needs.
Instead, both club and player appear aligned in ensuring that when he does return, he is not only pain-free but structurally stable, powerful and ready for sustained involvement.
There is also a personal benefit for the player: being involved in a cutting-edge rehabilitation programme can often accelerate mental confidence, allowing him to feel he is actively progressing rather than passively waiting.
Celtic may not see him until the spring, but when they do, they should be getting back a player fully prepared for the demands of top-level football, not someone rushed back into a cycle of setbacks.
And if Osmand returns for the season’s decisive months, his comeback could yet become one of the campaign’s most welcome boosts.
